Pharmaceutical Supply – Albuterol Sulfate and Other Respiratory Medications

The contract seeks the supply of FDA-approved albuterol sulfate and other respiratory medications packaged in sealed unit containers that meet all applicable shelf-life, labeling, storage, and regulatory requirements. Products must be manufactured, labeled, and distributed in full compliance with federal pharmaceutical standards to ensure safety, potency, and traceability throughout the supply chain. The agreement is structured as a subcontract under the Department of Defense’s Medical Supply Chain Pharm FSA, targeting the procurement of critical respiratory therapies for military and federal healthcare systems. All deliveries must adhere to precise handling and documentation protocols to maintain integrity from production to point of use. The solicitation was posted on July 20, 2026, with a firm response deadline of July 27, 2026, and is classified under NAICS code 325412, which pertains to pharmaceutical preparation manufacturing. There is no set-aside designation specified, meaning the contract is open to all qualified vendors regardless of business size or ownership structure. Performance is expected to support Defense Department medical logistics networks, though specific delivery locations are not detailed. Interested parties must access the official request via the DIBBS portal linked in the contract data to obtain full technical specifications, packaging requirements, and compliance documentation necessary for submission.